Research ArticleClinical Studies

Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus

TOSHIYASU OJIMA, MIKIHITO NAKAMORI, MASAKI NAKAMURA, MASAHIRO KATSUDA, KEIJI HAYATA, TOMOYA KATO, JUNYA KITADANI, HIROTAKA TABATA, AKIHIRO TAKEUCHI, MAKOTO IWAHASHI and HIROKI YAMAUE
Anticancer Research February 2016, 36 (2) 829-834;

Article Information

vol. 36 no. 2 829-834
PMID 
26851048
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received November 30, 2015
  • Revision received January 9, 2016
  • Accepted January 13, 2016
  • Published online February 5, 2016.
Copyright & Usage 
Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. TOSHIYASU OJIMA,
  2. MIKIHITO NAKAMORI,
  3. MASAKI NAKAMURA,
  4. MASAHIRO KATSUDA,
  5. KEIJI HAYATA,
  6. TOMOYA KATO,
  7. JUNYA KITADANI,
  8. HIROTAKA TABATA,
  9. AKIHIRO TAKEUCHI,
  10. MAKOTO IWAHASHI and
  11. HIROKI YAMAUE⇑
  1. Second Department of Surgery, Wakayama Medical University, Wakayama, Japan
  1. Correspondence to: Hiroki Yamaue, MD, Second Department of Surgery, Wakayama Medical University, School of Medicine, 811-1, Kimiidera, Wakayama 641-8510, Japan. Tel.: +81 734410612, Fax: +81 734466566, e-mail: yamaue-h{at}wakayama-med.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus
TOSHIYASU OJIMA, MIKIHITO NAKAMORI, MASAKI NAKAMURA, MASAHIRO KATSUDA, KEIJI HAYATA, TOMOYA KATO, JUNYA KITADANI, HIROTAKA TABATA, AKIHIRO TAKEUCHI, MAKOTO IWAHASHI, HIROKI YAMAUE
Anticancer Research Feb 2016, 36 (2) 829-834;
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords